065660 — Anterogen Co Income Statement
0.000.00%
Last trade - 00:00- KR₩305bn
- KR₩262bn
- KR₩8bn
Annual income statement for Anterogen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 8,122 | 6,591 | 6,500 | 6,933 | 7,536 |
| Cost of Revenue | |||||
| Gross Profit | 3,872 | 2,616 | 2,666 | 2,628 | 2,664 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 10,755 | 11,221 | 11,957 | 10,738 | 9,970 |
| Operating Profit | -2,633 | -4,630 | -5,457 | -3,805 | -2,433 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -554 | -6,850 | -2,841 | -2,293 | -1,094 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -554 | -6,837 | -2,841 | -2,293 | -1,374 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -554 | -6,837 | -2,841 | -2,293 | -1,374 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -554 | -6,837 | -2,841 | -2,293 | -1,374 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -95.6 | -709 | -253 | -230 | -138 |
| Dividends per Share |